UnknownPhase 4

Intravenous Tranexamic Acid During Rhytidectomy

United States40 participantsStarted 2019-05-30

Plain-language summary

This is a prospective, randomized, double-blind study investigating whether intravenous tranexamic acid has any effect on rhytidectomy surgery, or the subsequent postoperative sequelae. Intraoperative bleeding and postoperative ecchymosis and edema are subjectively rated and complications are noted.

Who can participate

Age range40 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Undergoing rhytidectomy surgery at Glasgold Group Plastic Surgery Exclusion Criteria: * History of bleeding disorder, history of thromboembolic events, history of seizure, active use of oral contraceptive pills or hormone replacement therapy, participant preference

What they're measuring

Intraoperative bleeding

Timeframe: Surgical time

Postoperative ecchymosis

Timeframe: Postoperative day 1

Postoperative ecchymosis

Timeframe: Postoperative day 6

Postoperative ecchymosis

Timeframe: Postoperative day 9

Postoperative edema

Timeframe: Postoperative day 1

Postoperative edema

Timeframe: Postoperative day 6

Postoperative edema

Timeframe: Postoperative day 9

Trial details

NCT IDNCT03970213

SponsorGlasgold Group Plastic Surgery

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-08-30

Contact for this trial

Mark J Glasgold, MD

732-846-6540 mglasgold@gmail.com

View on ClinicalTrials.gov More Bleeding trials